Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmadrug Inc
C.PHRX
Alternate Symbol(s):
LMLLF
Medical Care
Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural...
medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(182)
•••
Chritters
X
View Profile
View Bullboard History
Post by
Chritters
on Nov 23, 2021 11:47am
Dales report Video
FDA Approval end of Nov!! https://www.youtube.com/watch?v=X3KoaVhJ8VE
(15)
•••
SamRothstein
X
View Profile
View Bullboard History
Comment by
SamRothstein
on Nov 23, 2021 9:27am
RE:.04
That is why they are outsourcing their trials. To preserve cash.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 22, 2021 2:15pm
.04
.04 company is going into cancer research....put on your anti gravity belts....idiots
(15)
•••
SamRothstein
X
View Profile
View Bullboard History
Comment by
SamRothstein
on Nov 18, 2021 6:44pm
RE:I call bullsht sammy
Based on your posts I think you might need some kind of professional help.
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 18, 2021 11:33am
I call bullsht sammy
U a$$hat
(15)
•••
SamRothstein
X
View Profile
View Bullboard History
Post by
SamRothstein
on Nov 18, 2021 9:51am
Positive reults from preclinical study on4 different cancers
PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple Cancers Results of the 4 cancer types where cepharanthine provides
...more
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 17, 2021 10:52pm
prison
https://www.canadabulls.com/m/SignalPage.aspx?lang=en&Ticker=PHRX.CD
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 17, 2021 10:49pm
no blindfold
for daniel
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 17, 2021 10:48pm
bury them facedown
it's good for business
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 17, 2021 10:47pm
Daniel Cohen
let's give him a star.
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 17, 2021 10:44pm
this is why I like trains
With a final destination .
(67)
•••
Losermachine
X
View Profile
View Bullboard History
Post by
Losermachine
on Nov 17, 2021 7:47pm
This jakzero fkn company
could not win a game of chess with a feral blind panda bear from India. but eye desease? oh fkn yeah got that covered... what a bunch of sht in a cast iron pan for breakfast....good fn luck...
(15)
•••
SamRothstein
X
View Profile
View Bullboard History
Comment by
SamRothstein
on Nov 14, 2021 3:32pm
RE:VIP reservation for Sam and GOLDY
At least I am free to travel. Unlike you I don't have ankle monitors or parole officers to contend with.
(15)
•••
SamRothstein
X
View Profile
View Bullboard History
Comment by
SamRothstein
on Nov 13, 2021 12:46pm
RE:Post from lieing SAM
You have had your new nic for less than 24 hours and have already proven you are a just another garbage can nic in a sea of garbage scam bashers.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden